Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03953235
Title A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Gritstone Oncology, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Arizona Phoenix Arizona 85054 United States Details
UCLA Medical Center Santa Monica California 90404 United States Details
Mayo Clinic Florida Jacksonville Florida 32224 United States Details
University of Chicago Medicine, Comprehensive Cancer Center Chicago Illinois 60637 United States Details
Mayo Clinic Rochester Rochester Minnesota 55905 United States Details
Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field